Skip to main content

Medicare LCD list by contractor, page 2 of 5

This page continues the contractor-grouped list of all 851 active Local Coverage Determinations in the Medicare Coverage Database export of November 12, 2026, which starts on the LCD hub. It lists 225 policies from First Coast Service Options, Inc., Noridian Healthcare Solutions, LLC, Novitas Solutions, Inc.: 84 link to a full reference page and 141 are listed as text, and 201 of them have a billing and coding article with covered ICD-10-CM codes.

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: Medicare Coverage Database LCD export: MCD release November 12, 2026 (effective November 8, 2026); Medicare Coverage Database billing and coding articles: MCD release November 12, 2026 (effective November 8, 2026). Next CMS release: weekly, every Thursday.

Policies on this page

First Coast Service Options, Inc. (continued) 79 policies · 3 states

Show 57 other First Coast Service Options, Inc. policies on this page (pages not in search results)
  • L33261 Allergy Testing
  • L33267 B-Type Natriuretic Peptide (BNP)
  • L33274 Botulinum Toxins
  • L33609 Autonomic Function Tests
  • L33671 Diagnostic Colonoscopy
  • L33689 Mohs Micrographic Surgery (MMS)
  • L33693 Peripheral Venous Ultrasound
  • L33751 Scanning Computerized Ophthalmic Diagnostic Imaging (SCODI)
  • L33756 Transesophageal Echocardiogram
  • L33774 Wireless Capsule Endoscopy
  • L33813 Destruction of Malignant Skin Lesions
  • L33818 Excision of Malignant Skin Lesions
  • L33833 Surgical Treatment of Nails
  • L33906 Epidural Steroid Injections for Pain Management
  • L33912 Trigger Point Injections
  • L33922 Nail Debridement
  • L33923 Noninvasive Ear or Pulse Oximetry For Oxygen Saturation
  • L33930 Facet Joint Interventions for Pain Management
  • L33941 Routine Foot Care
  • L33958 Somatosensory Testing
  • L33967 Vitamin B<sub>12</sub> Injections
  • L33975 Psychiatric Inpatient Hospitalization
  • L34007 Immune Globulin
  • L34021 Sedimentation Rate, Erythrocyte
  • L34027 Ultrasound, Soft Tissues of Head and Neck
  • L34028 Blepharoplasty, Blepharoptosis Repair and Surgical Procedures of the Brow
  • L34372 Magnetic Resonance Angiography (MRA)
  • L34519 Molecular Pathology Procedures
  • L34522 Transcranial Magnetic Stimulation (TMS) in the Treatment of Adults with Major Depressive Disorder
  • L34859 Nerve Conduction Studies and Electromyography
  • L36393 Controlled Substance Monitoring and Drugs of Abuse Testing
  • L36499 BRCA1 and BRCA2 Genetic Testing
  • L37166 Wound Care
  • L37398 Electroretinography (ERG)
  • L37564 Frequency of Hemodialysis
  • L37798 4Kscore Test Algorithm
  • L37800 Allergen Immunotherapy
  • L38227 Gastrointestinal Pathogen (GIP) Panels Utilizing Multiplex Nucleic Acid Amplification Techniques (NAATs)
  • L38231 Endovenous Stenting
  • L38233 Micro-Invasive Glaucoma Surgery (MIGS)
  • L38396 Cardiology Non-emergent Outpatient Stress Testing
  • L38398 Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep Apnea
  • L38664 Implantable Continuous Glucose Monitors (I-CGM)
  • L38720 Treatment of Chronic Venous Insufficiency of the Lower Extremities
  • L38726 Transurethral Waterjet Ablation of the Prostate
  • L38914 Cosmetic and Reconstructive Surgery
  • L38918 Respiratory Pathogen Panel Testing
  • L38926 Cataract Extraction (including Complex Cataract Surgery)
  • L39071 Platelet Rich Plasma
  • L39073 Pharmacogenomics Testing
  • L39084 Genetic Testing for Cardiovascular Disease
  • L39367 Genetic Testing in Oncology: Specific Tests
  • L39492 Ambulatory Electrocardiograph (AECG) Monitoring
  • L39799 Cervical Fusion
  • L39877 Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
  • L40289 Non-invasive Arterial Duplex Ultrasound of the Upper and Lower Extremities
  • L40380 Urine-based Biomarkers in Patients with Microhematuria

Noridian Healthcare Solutions, LLC 113 policies · 32 states

Show 84 other Noridian Healthcare Solutions, LLC policies on this page (pages not in search results)
  • L34209 Treatment of Varicose Veins of the Lower Extremities
  • L34218 Injections - Tendon, Ligament, and Ganglion Cyst
  • L34228 Percutaneous Vertebral Augmentation (PVA) for Osteoporotic Vertebral Compression Fracture (VCF)
  • L35160 MolDX: Molecular Diagnostic Tests (MDT)
  • L35170 Botulinum Toxin Injections
  • L35172 Botulinum Toxin Injections
  • L35702 Mohs Micrographic Surgery
  • L36188 MolDX: MGMT Promoter Methylation Analysis
  • L36335 MolDX: NRAS Genetic Testing
  • L36351 Lab: Special Histochemical Stains and Immunohistochemical Stains
  • L36353 Lab: Special Histochemical Stains and Immunohistochemical Stains
  • L36358 MolDX: Biomarkers in Cardiovascular Risk Assessment
  • L36380 MolDX: Breast Cancer Assay: Prosigna®
  • L36524 Nerve Conduction Studies and Electromyography
  • L36551 MolDX: HLA-DQB1*06:02 Testing for Narcolepsy
  • L36668 Urine Drug Testing
  • L36692 Vitamin D Assay Testing
  • L36704 ProMark® Risk Score
  • L36846 Measurement of Salivary Hormones
  • L36861 Polysomnography and Other Sleep Studies
  • L36864 GlycoMark® Testing for Glycemic Control
  • L36941 MolDX: Oncotype DX® Breast Cancer for DCIS (Genomic Health™)
  • L37054 BDX-XL2
  • L37066 Lab: Coenzyme Q10 (CoQ10)
  • L37070 MolDX: DecisionDx-UM (Uveal Melanoma)
  • L37086 Transcranial Magnetic Stimulation (TMS)
  • L37295 MolDX: EndoPredict® Breast Cancer Gene Expression Test
  • L37299 MolDX: Prometheus® IBD sgi Diagnostic® Policy
  • L37502 Frequency of Hemodialysis
  • L37620 MDS FISH
  • L37628 In Vitro Chemosensitivity & Chemoresistance Assays
  • L37729 Magnetic-Resonance-Guided Focused Ultrasound Surgery (MRgFUS) for Essential Tremor and Tremor Dominant Parkinson's Disease
  • L37750 MolDX: Melanoma Risk Stratification Molecular Testing
  • L37822 MolDX: Breast Cancer Index® (BCI) Gene Expression Test
  • L37887 MolDX: Envisia™, Veracyte™, Idiopathic Pulmonary Fibrosis Diagnostic Test
  • L37897 MolDX: Inivata™, InVisionFirst®, Liquid Biopsy for Patients with Lung Cancer
  • L38119 MolDX: Next-Generation Sequencing for Solid Tumors
  • L38123 MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies
  • L38151 MolDX: Pigmented Lesion Assay
  • L38299 Micro-Invasive Glaucoma Surgery (MIGS)
  • L38310 Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep Apnea
  • L38327 MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer
  • L38331 MolDX: Blood Product Molecular Antigen Typing
  • L38335 MolDX: Pharmacogenomics Testing
  • L38339 MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease
  • L38351 MolDX: Repeat Germline Testing
  • L38613 Non-Invasive Fractional Flow Reserve (FFR) for Ischemic Heart Disease
  • L38643 MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells
  • L38647 MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer
  • L38657 Implantable Continuous Glucose Monitors (I-CGM)
  • L38705 Transurethral Waterjet Ablation of the Prostate
  • L38801 Facet Joint Interventions for Pain Management
  • L38824 Colon Capsule Endoscopy (CCE)
  • L38972 MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
  • L39001 MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing
  • L39005 MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer
  • L39058 Platelet Rich Plasma Injections for Non-Wound Injections
  • L39116 Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
  • L39230 MolDX: Plasma-Based Genomic Profiling in Solid Tumors
  • L39262 MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia
  • L39373 MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma
  • L39396 Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin's and Non-Hodgkin's Lymphoma with B-cell or T-cell Origin
  • L39462 Sacroiliac Joint Injections and Procedures
  • L39467 MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis
  • L39589 MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell Carcinoma
  • L39678 MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy
  • L39682 MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules
  • L39686 MolDX: Gene Expression Profile Tests for Decision-Making in Castration Resistant and Metastatic Prostate Cancers
  • L39758 Cervical Fusion
  • L39810 Minimally Invasive Arthrodesis of the Sacroiliac Joint (SIJ)
  • L39881 Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT )/Coronary Plaque Analysis (AI-CPA)
  • L39923 MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms
  • L39944 MolDX: Genetic Testing for Heritable Thoracic Aortic Disease
  • L39948 MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis
  • L39960 Intervertebral Disc Repair
  • L40050 Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT)
  • L40060 MolDX: Molecular Testing for Solid Organ Allograft Rejection
  • L40062 MolDX: Molecular Testing for Solid Organ Allograft Rejection
  • L40176 Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC)
  • L40197 MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis
  • L40222 MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Targeted Therapy in Cancer
  • L40242 MolDX: Genetic Testing for Hereditary Thrombophilia
  • L40265 Peripheral Nerve Injections and Procedures for Chronic Pain
  • L40324 Allergy Diagnostic Testing

Novitas Solutions, Inc. 71 policies · 12 states · continues on the next page

How the list is ordered

Each active policy appears once, under the first Medicare Administrative Contractor hub that lists it, in the order of the contractor hubs; policies that no A/B contractor hub lists, which are the durable medical equipment, home health and hospice policies, close the list. Inside a contractor, the policies with a full reference page come first, ordered by how often people search for the policy number, and the contractor's other policies follow as text in policy-number order. A contractor whose policies run across a page break is marked as continued, and the contractor hub always lists every active policy in that jurisdiction on one page.

Reading a local coverage policy

A Local Coverage Determination applies only to claims processed by the contractor that wrote it, so start from the contractor for the state where the service is furnished, or from the durable medical equipment contractor region for supplies and equipment. Then check the date of service against the policy's revision date: a revision that adds or removes diagnosis codes changes which claims pass the edit from that date forward.

The policy text sets out the covered indications, limitations and documentation requirements. Since January 2019 the procedure and diagnosis codes have lived in a companion billing and coding article, which is what the contractor loads as the claims edit; each policy page here shows the article's covered-code count with a sample and opens the full covered and non-covered lists. A policy listed as text on this page still has its own page with the same data; it is kept out of search results because it is another contractor's version of a title that its topic comparison covers, or a short policy with little search demand.

Other ways to find a policy

The LCD code lookup answers the question for one procedure code, one state and one diagnosis. The LCD lookup guide explains contractor jurisdictions and the appeal path, the NCD guide explains when a national policy overrides a local one, and the LCD coverage variation report shows how far the versions of a shared title differ between contractors. The topic list on the hub links every title that several contractors publish.

For teams evaluating QuickIntell software

Where QuickIntell fits with this policy

If your team repeatedly reviews local coverage policies, explore QuickAuth for requirement checks, documentation and status tracking with staff oversight. Confirm the applicable policy, supported workflow and review responsibilities. Use QuickRCM to evaluate the separate claim and denial workflow.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

Policy metadata and code counts are reproduced from the CMS Medicare Coverage Database export as an operational reference. Verify against the current LCD and article on cms.gov before billing. This continuation page is kept out of search results; the LCD hub and each policy's own page are the pages meant to be found. Not legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.